Market cap
$16.828 B
$602.90 -2.84%
Close of 7 Oct 2026
As of 7 Oct 2026, Medpace (MEDP) has a market capitalization of $16.8B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$2.53B
#1013 by revenue
Earnings
$451.1M
#658 by earnings
Shares outstanding
27,911,655
Latest filing cover page
P/E ratio
37.3
Cap ÷ net income
Biotechnology: Commercial Physical & Biological Resarch, ranked by market cap
All 12 →- #1IqviaIQV$42.8B
- #2IncyteINCY$22.9B
- #3MedpaceMEDP$16.8B
- #4Charles River Laboratories InternationalCRL$14.6B
- #5IconICLR$12.4B
What if Medpace were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Medpace are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.